Q2 2025 Agilent Technologies Inc Earnings Call Transcript
Key Points
- Agilent Technologies Inc (A) reported strong second-quarter results with revenue of $1.67 billion, representing a 6% increase year-over-year.
- The company achieved an operating margin of 25.1% despite absorbing incremental tariff costs.
- Agilent's EPS grew by 7% compared to the second quarter of 2024, marking the fourth consecutive quarter of accelerating growth.
- The company saw growth across all regions, with China leading at 10% growth, and strong performance in India with high teens growth.
- Agilent's PFAS testing business grew more than 70% year-over-year globally, contributing significantly to the company's growth.
- The academia and government end market declined modestly, with a 2% decrease in the quarter.
- Biopharma growth was slower, with low single-digit growth due to funding challenges in small and midsized biotech, primarily in the US.
- The company faced a mid-single-digit decline in its NGS business.
- Agilent had to absorb 55 basis points of incremental tariff costs, impacting gross margins.
- The company anticipates potential additional tariff impacts if US-EU tariffs increase, which could add $40 million in gross exposure in the second half of the year.
Good afternoon, my name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to the second quarter 2025 Agilent Technologies Inc earnings conference call.
(Operator Instructions) Thank you. Parmeet Ahuja, you may begin the conference.
Thank you and welcome everyone to Agilent's conference call for the second quarter of fiscal year 2025. With me are Padraig McDonnell, Agilent President and CEO; and Bob McMahon, Agilent Senior Vice President and CFO.
Joining the Q&A will be Simon May, President of the Life Sciences and Diagnostics Markets Group; Angelica Riemann, President of the Agilent CrossLab Group; and Mike Zhang, President of Applied Markets Group.
This presentation is being webcast live. The press release for our second quarter financial results, investor presentation, and information to supplement today's discussion, along with the recording of this webcast, are available on our website at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
